Acura Pharmaceuticals Competitors and Similar CompaniesClear all

Acura Pharmaceuticals's competitors and similar companies include Advanced Biotechnologies, Genentech, Vertex Pharmaceuticals and YiChang HEC ChangJiang Pharmaceutical.

	Acura Pharmaceuticals Acura Pharmaceuticals is a specialty pharmaceutical company developing and commercializing tamper-resistant products to combat medication abuse and misuse.	Advanced Biotechnologies Advanced Biotechnologies is a company specializing in viral reagents and infectious disease antigens.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.	YiChang HEC ChangJiang Pharmaceutical YiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products.
Founding Date	Founding Date 1935	Founding Date 1982	Founding Date 1976	Founding Date 1989	Founding Date 2001
Type	Type Public	Type Private	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Manufacturing & Industrial biotech contractor pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Palatine, US HQ Culver, US	Locations Bethesda, US HQ	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Boston, US HQ St Leonards, AU Wien, AT Bruxelles, BE São Paulo, BR Toronto, CA Praha, CZ see more	Locations HQ
Employees	Employees 925% decrease	Employees 21	Employees 18,077	Employees 5,40013% increase	Employees 4,595
Valuation ($)	Valuation ($) 92.4 k	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 121.4 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $1.6m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $12b (FY, 2025)	Revenue (est.) ¥3.7b (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $1.7b (FY, 2025)	Cost of goods ¥533.6m (FY, 2024)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $10.4b (FY, 2025)	Gross profit ¥3.2b (FY, 2024)
Net income	Net income ($879k) (FY, 2021)	Net income N/A	Net income N/A	Net income N/A	Net income ¥482.7m (FY, 2024)
Operating ⚠
Products	Products N/A	Products 26 (Nov, 2022)	Products N/A	Products 6 (FY, 2022)	Products N/A
Funding
Total funding raised	Total funding raised $ 75.8m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 2.4m	Total funding raised N/A